Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2936.5%
operating margin TTM
-2975.47%
revenue TTM
93.99 Thousand
revenue per share TTM
0.04$
valuation ratios | |
|---|---|
| pe ratio | -3.47 |
| peg ratio | -0.11 |
| price to book ratio | 28.04 |
| price to sales ratio | 13.92 |
| enterprise value multiple | -0.48 |
| price fair value | 28.04 |
profitability ratios | |
|---|---|
| gross profit margin | 56.91% |
| operating profit margin | -2975.47% |
| pretax profit margin | -2936.5% |
| net profit margin | -2936.5% |
| return on assets | -170.65% |
| return on equity | -303.2% |
| return on capital employed | -431.7% |
liquidity ratio | |
|---|---|
| current ratio | 0.97 |
| quick ratio | 0.91 |
| cash ratio | 0.77 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 580.52 |
| operating cycle | 725.02 |
| days of payables outstanding | 2,200.90 |
| cash conversion cycle | -1,475.87 |
| receivables turnover | 2.53 |
| payables turnover | 0.17 |
| inventory turnover | 0.63 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.48 |
| debt equity ratio | 2.28 |
| long term debt to capitalization | 0.24 |
| total debt to capitalization | 0.70 |
| interest coverage | -32.91 |
| cash flow to debt ratio | -2.96 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.47 |
| cash per share | 0.44 |
| operating cash flow per share | -1.35 |
| free cash flow operating cash flow ratio | 1.09 |
| cash flow coverage ratios | -2.96 |
| short term coverage ratios | -4.44 |
| capital expenditure coverage ratio | -11.55 |
Frequently Asked Questions
When was the last time Mainz Biomed B.V. (NASDAQ:MYNZ) reported earnings?
Mainz Biomed B.V. (MYNZ) published its most recent earnings results on 09-04-2024.
What is Mainz Biomed B.V.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Mainz Biomed B.V. (NASDAQ:MYNZ)'s trailing twelve months ROE is -303.2%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Mainz Biomed B.V. (MYNZ) currently has a ROA of -170.65%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MYNZ's net profit margin stand at?
MYNZ reported a profit margin of -2936.5% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MYNZ's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.97 in the most recent quarter. The quick ratio stood at 0.91, with a Debt/Eq ratio of 2.28.